Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
134,553,130
-
Total 13F shares
-
12,276,773
-
Share change
-
+5,188,938
-
Total reported value
-
$21,734,954
-
Price per share
-
$1.77
-
Number of holders
-
47
-
Value change
-
+$9,093,088
-
Number of buys
-
29
-
Number of sells
-
12
Institutional Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q1 2019
As of 31 Mar 2019,
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,276,773 shares.
The largest 10 holders included
BVF INC/IL, ARMISTICE CAPITAL, LLC, COWEN INC., Redmile Group, LLC, BlackRock Inc., VANGUARD GROUP INC, Tekla Capital Management LLC, Granite Point Capital Management, L.P., RENAISSANCE TECHNOLOGIES LLC, and WELLS FARGO & COMPANY/MN.
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.